Low/moderate risk CAP with no comorbidities
amoxicillin
doxycycline
azithromycin or clarithromycin
low/moderate risk CAP w/ comorbidities
amox-clav or cephalosporin
plus
doxycycline or macrolide
OR
fluoroquinolone
High risk CAP
B- lactam plus macrolide
B-lacatam plus doxy
Fluoroquinolone
Norepinephrine
a and b, increase SVR and HR, some CO
Distributive shock
Preload down
CO down
Afterload down
Epinephrine
a and b (less selectivity)
increase SVR, HR, CO
*limited by tachycardia
Phenylephrine
a only
increase SVR
*ceiling effect
Mild nonpurulent cellulitis
cephalexin
amox-clav
dicloxacillin
IV moderate cellulitis
Cefazolin
Ceftriaxone
Mild purulent non-MRSA
cephalexin, dicloxacillin
MRSA cellulitis PO
TMP-SMX, doxycycline
MAP equation
(SBP + 2xDBP)/3
Sedatives with hepatic dosing
Midazolam
Ketamine
Propylene glycol toxicity
Lorazepam
Barbiturates
SUP-ICU
pantoprazole vs placebo
PEPTIC
PPI vs H2RA in mechanical ventilation
REVISE
pantoprazole vs placebo in mechanical ventilation
Cardiogenic shock
preload up
cardiac output down
afterload up
Hypovolemic shock
preload down
cardiac output down
afterload up